Evidence map›Paper›PMID 26791188›Full record

ReviewThe American journal of clinical nutrition2016

Long-chain polyunsaturated fatty acids and the preterm infant: a case study in developmentally sensitive nutrient needs in the United States.

J Thomas Brenna

Open access · bronzeAbstract readReview
In one paragraph

Review in The American journal of clinical nutrition, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Nutrition and Brain Development.Current topics in behavioral neurosciences · 2022
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Brown but not white adipose cells synthesize omega-3 docosahexaenoic acid in culture.Prostaglandins, leukotrienes, and essential fatty acids · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

J Thomas BrennaDivision of Nutritional Sciences, Cornell University, Ithaca, NY jtb4@cornell.edu.ORCID http://orcid.org/0000-0001-9494-4245
Cornell University · US

Funding

DHA Supplementation and Pregnancy OutcomeR01HD047315 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CARLSON, SUSAN E, COLOMBO, JOHN A. · 2006 to 2016
$4.9M
Molecular mechanism of omega-3 responseR01AT007003 · NCCIH · UNIVERSITY OF TEXAS AT AUSTIN · PI BRENNA, JAMES T. · 2013 to 2017
$1.9M
NCCIH NIH HHS R01 AT007003NICHD NIH HHS R01 HD047315
6 · The paper itself

Abstract

The vast majority of infant formulas in the United States contain the long-chain polyunsaturated fatty acids (PUFAs) docosahexaenoic acid (22:6n-3) and arachidonic acid (20:4n-6), which were first permitted by the US Food and Drug Administration in 2001. As a scientific case study, preclinical animal studies of these nutrients definitively influenced the design and interpretation of human clinical studies. Early studies were tied to the availability of test substances, and in hindsight suggest re-evaluation of the essential fatty acid concept in light of the totality of available evidence. Research in the 1950s established the essentiality of n-6 PUFAs for skin integrity; however, widespread recognition of the essentiality of n-3 PUFAs came decades later despite compelling evidence of their significance. Barriers to an understanding of the essentiality of n-3 PUFAs were as follows: 1) their role is in neural function, which is measured only with difficulty compared with skin lesions and growth faltering that are apparent for n-6 PUFAs; 2) the experimental use of vegetable oils as PUFA sources that contain the inefficiently used C18 PUFAs rather than the operative C20 and C22 PUFAs; 3) the shift from reliance on high-quality animal studies to define mechanisms that established the required nutrients in the first part of the 20th century to inherently challenging human studies. Advances in nutrition of premature infants require the best practices and opinions available, taking into account the totality of preclinical and clinical evidence.

Indexed as

Child DevelopmentEvidence-Based MedicineInfant Nutritional Physiological PhenomenaAnimalsCongresses as TopicFatty Acids, EssentialFatty Acids, Omega-3Fatty Acids, Omega-6HumansInfant FormulaInfant, NewbornNeurogenesisNutritional RequirementsPractice Guidelines as TopicPremature BirthUnited StatesFatty Acids, EssentialFatty Acids, Omega-3Fatty Acids, Omega-6arachidonic aciddocosahexaenoic acidessential fatty acidsLC-PUFApreterm infants

Identifiers

PMID26791188
PMCPMC4733252
OpenAlexW2255080776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.